Replies to post #55091 on Ayala Pharmaceuticals Inc (fka ADXS)

[CATTDOGG12347]

Your wrong....

[ignatiusrielly35]

Partially validate the entire platform and could influence other agencies to approve it as well. Plus the revenue.

[HVACmaster]

Dew, you said "ADXS can probably wait until 2018 to raise capital. By then, they may have some news (e.g. the AXAL MAA submission in cervical cancer) to lift the share price and make the dilution less onerous." post 215703

Nothing seems to make sense here..the SP should have seen a boost...
The company has 4 major BP partners/ collaborators, almost a year of operating cash, no debt, validated technology, in a cutting edge sector of oncology, multiple upcoming catalysts etc. etc.
And it is awarded a 100mm Market Cap

[MadCityCyclone]

in what sense?

[gajj]

yes cervical cancer is a minor issue. China, India, very limited potential. LOl. ha ha ha ha

[DewDiligence]

The AXAL MAA was never as consequential as some message-board posters thought. I commented on this in #msg-138560445 (from Feb 2018).